Cargando…

Gender Difference in the Association Between Metabolic Factors and Hepatocellular Carcinoma

BACKGROUND: A gender difference in hepatocellular carcinoma (HCC) that men have higher incidence than women has long been noted and can be explained by the cross-talk between sex hormones and hepatitis B virus/hepatitis C virus (HBV/HCV). Whether metabolic factors yield similar sexual difference in...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chi-Ling, Kuo, Ming-Jeng, Yen, Amy Ming-Fang, Yang, Wei-Shiung, Kao, Jia-Horng, Chen, Pei-Jer, Chen, Hsiu-Hsi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583157/
https://www.ncbi.nlm.nih.gov/pubmed/33134821
http://dx.doi.org/10.1093/jncics/pkaa036
_version_ 1783599344331522048
author Chen, Chi-Ling
Kuo, Ming-Jeng
Yen, Amy Ming-Fang
Yang, Wei-Shiung
Kao, Jia-Horng
Chen, Pei-Jer
Chen, Hsiu-Hsi
author_facet Chen, Chi-Ling
Kuo, Ming-Jeng
Yen, Amy Ming-Fang
Yang, Wei-Shiung
Kao, Jia-Horng
Chen, Pei-Jer
Chen, Hsiu-Hsi
author_sort Chen, Chi-Ling
collection PubMed
description BACKGROUND: A gender difference in hepatocellular carcinoma (HCC) that men have higher incidence than women has long been noted and can be explained by the cross-talk between sex hormones and hepatitis B virus/hepatitis C virus (HBV/HCV). Whether metabolic factors yield similar sexual difference in non-HBV/HCV-HCC remains elusive. METHODS: There were 74 782 hepatitis B surface antigen (HBsAg)/antibody to hepatitis C virus (anti-HCV) negative residents who participated in the Keelung Community-Based Integrated Screening program and were followed in 2000-2007. Incident HCC was identified by linkage to the Taiwan Cancer Registry. Cox proportional hazards regression models were used to estimate the association between metabolic factors and HCC stratified by sex. All statistical tests were 2-sided. RESULTS: With 320 829 follow-up person-years, 99 residents developed HCC. The adjusted hazard ratios (aHR) were 2.10 (95% confidence interval [CI] = 1.07 to 4.13) and 3.71 (95% CI = 2.01 to 6.86) for prediabetes and diabetes, respectively, in men. The corresponding adjusted hazard ratios were 1.16 (95% CI = 0.48 to 2.83) and 1.47 (95% CI = 0.65 to 3.34) in women. Compared with normal weight (body mass index [BMI] = 23-25), underweight (BMI < 21, HR = 3.56, 95% CI = 1.18 to 10.8) and overweight (BMI = 25 to <27.3, HR = 3.81, 95% CI = 1.43 to 10.2) were associated with an elevated risk in men. The statistically significant gradient relationship per advanced BMI category was noted in women (aHR = 1.41, 95% CI = 1.07 to 1.87). The HCC–fasting glucose (P = .046) and HCC-BMI (P = .03) associations were statistically significantly modified by sex. Elevated aspartate aminotransferase, aspartate aminotransferase-to-platelet index and fibrosis index, and habitual alcohol consumption were related to HCC only in men, whereas increased alanine aminotransferase and lower platelet levels predicted HCC risk in women. CONCLUSIONS: We found that BMI-HCC associations were U-shape for men and linear for women, and the elevated HCC risk began from glucose impairment in men only. Whether good glycemic and weight control can reduce HCC risk warrants further investigation.
format Online
Article
Text
id pubmed-7583157
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-75831572020-10-29 Gender Difference in the Association Between Metabolic Factors and Hepatocellular Carcinoma Chen, Chi-Ling Kuo, Ming-Jeng Yen, Amy Ming-Fang Yang, Wei-Shiung Kao, Jia-Horng Chen, Pei-Jer Chen, Hsiu-Hsi JNCI Cancer Spectr Article BACKGROUND: A gender difference in hepatocellular carcinoma (HCC) that men have higher incidence than women has long been noted and can be explained by the cross-talk between sex hormones and hepatitis B virus/hepatitis C virus (HBV/HCV). Whether metabolic factors yield similar sexual difference in non-HBV/HCV-HCC remains elusive. METHODS: There were 74 782 hepatitis B surface antigen (HBsAg)/antibody to hepatitis C virus (anti-HCV) negative residents who participated in the Keelung Community-Based Integrated Screening program and were followed in 2000-2007. Incident HCC was identified by linkage to the Taiwan Cancer Registry. Cox proportional hazards regression models were used to estimate the association between metabolic factors and HCC stratified by sex. All statistical tests were 2-sided. RESULTS: With 320 829 follow-up person-years, 99 residents developed HCC. The adjusted hazard ratios (aHR) were 2.10 (95% confidence interval [CI] = 1.07 to 4.13) and 3.71 (95% CI = 2.01 to 6.86) for prediabetes and diabetes, respectively, in men. The corresponding adjusted hazard ratios were 1.16 (95% CI = 0.48 to 2.83) and 1.47 (95% CI = 0.65 to 3.34) in women. Compared with normal weight (body mass index [BMI] = 23-25), underweight (BMI < 21, HR = 3.56, 95% CI = 1.18 to 10.8) and overweight (BMI = 25 to <27.3, HR = 3.81, 95% CI = 1.43 to 10.2) were associated with an elevated risk in men. The statistically significant gradient relationship per advanced BMI category was noted in women (aHR = 1.41, 95% CI = 1.07 to 1.87). The HCC–fasting glucose (P = .046) and HCC-BMI (P = .03) associations were statistically significantly modified by sex. Elevated aspartate aminotransferase, aspartate aminotransferase-to-platelet index and fibrosis index, and habitual alcohol consumption were related to HCC only in men, whereas increased alanine aminotransferase and lower platelet levels predicted HCC risk in women. CONCLUSIONS: We found that BMI-HCC associations were U-shape for men and linear for women, and the elevated HCC risk began from glucose impairment in men only. Whether good glycemic and weight control can reduce HCC risk warrants further investigation. Oxford University Press 2020-05-08 /pmc/articles/PMC7583157/ /pubmed/33134821 http://dx.doi.org/10.1093/jncics/pkaa036 Text en © The Author(s) 2020. Published by Oxford University Press. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Article
Chen, Chi-Ling
Kuo, Ming-Jeng
Yen, Amy Ming-Fang
Yang, Wei-Shiung
Kao, Jia-Horng
Chen, Pei-Jer
Chen, Hsiu-Hsi
Gender Difference in the Association Between Metabolic Factors and Hepatocellular Carcinoma
title Gender Difference in the Association Between Metabolic Factors and Hepatocellular Carcinoma
title_full Gender Difference in the Association Between Metabolic Factors and Hepatocellular Carcinoma
title_fullStr Gender Difference in the Association Between Metabolic Factors and Hepatocellular Carcinoma
title_full_unstemmed Gender Difference in the Association Between Metabolic Factors and Hepatocellular Carcinoma
title_short Gender Difference in the Association Between Metabolic Factors and Hepatocellular Carcinoma
title_sort gender difference in the association between metabolic factors and hepatocellular carcinoma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583157/
https://www.ncbi.nlm.nih.gov/pubmed/33134821
http://dx.doi.org/10.1093/jncics/pkaa036
work_keys_str_mv AT chenchiling genderdifferenceintheassociationbetweenmetabolicfactorsandhepatocellularcarcinoma
AT kuomingjeng genderdifferenceintheassociationbetweenmetabolicfactorsandhepatocellularcarcinoma
AT yenamymingfang genderdifferenceintheassociationbetweenmetabolicfactorsandhepatocellularcarcinoma
AT yangweishiung genderdifferenceintheassociationbetweenmetabolicfactorsandhepatocellularcarcinoma
AT kaojiahorng genderdifferenceintheassociationbetweenmetabolicfactorsandhepatocellularcarcinoma
AT chenpeijer genderdifferenceintheassociationbetweenmetabolicfactorsandhepatocellularcarcinoma
AT chenhsiuhsi genderdifferenceintheassociationbetweenmetabolicfactorsandhepatocellularcarcinoma